COMMUNIQUÉS West-GlobeNewswire

BioTelemetry, Inc. Elects Laura Dietch and Tiffany Olson to its Board of Directors
28/02/2019
MALVERN, Pa., Feb. 28, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of [...]
CLS Holdings USA, Inc Redeems All Outstanding Yorkville Convertible Debentures Outstanding
28/02/2019
LAS VEGAS, Feb. 28, 2019 (GLOBE NEWSWIRE) -- CLS Holdings USA Inc. (OTCQB:CLSH) (CSE:CLSH.U) “CLS”, a diversified cannabis company operating as Cannabis Life Sciences, has redeemed all of its convertible debentures [...]
American Cannabis Company, Inc. Announces It Has Secured An Industrial Hemp Services Contract With A New Client In The State Of Alabama & Will Be Working With The University Of Alabama On Hemp Research
28/02/2019
DENVER, CO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business cannabis and hemp consulting solutions provider, is pleased to [...]
MyoKardia Reports Fourth Quarter and Full Year 2018 Financial Results
28/02/2019
Company to Host Conference Call and Webcast on March 4, 2019 at 8:30 a.m. ET (5:30 a.m. PT) SOUTH SAN FRANCISCO, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage [...]
Avinger to Announce Fourth Quarter and Full Year 2018 Financial Results on March 6, 2019
28/02/2019
REDWOOD CITY, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for [...]
Hemispherx Biopharma Announces Extension of Rights Offering Period to March 5, 2019
28/02/2019
OCALA, Fla., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) (“Hemispherx” or the “Company”), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical [...]
Save the Date: Profound Medical to Host Inaugural Analyst & Investor Day on April 11
28/02/2019
TORONTO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that combines real-time Magnetic Resonance (“MR [...]
Samumed Announces Positive End-of-Phase 2 Meeting with FDA for SM04690 in Knee Osteoarthritis
28/02/2019
STRIDES Phase 3 studies to commence first half of 2019 SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has successfully completed an End-of-Phase 2 meeting with the U.S. Food and Drug [...]
OncBioMune Announces Consulting Agreement with CATO Research LLC for Developing PGT, a Protein Drug Complex Targeting CD71 for Refractory Cancers
28/02/2019
BATON ROUGE, La., Feb. 28, 2019 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2019
28/02/2019
CORAL GABLES, Fla., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Daré Bioscience, Inc. to Present at the 16th Annual BIO Asia International Conference
28/02/2019
SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson, President and Chief Executive Officer, will present at the [...]
Aeglea BioTherapeutics to Host Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights Conference Call
28/02/2019
AUSTIN, Texas, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (Nasdaq:AGLE) a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare [...]
Jounce Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Wednesday, March 6, 2019
28/02/2019
CAMBRIDGE, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]
UAHC Subsidiary American Sustainable Rubber Company, LLC Appoints Leading Plant Researcher Dr. Katrina Cornish as Scientific Advisor
28/02/2019
CHICAGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- United American Healthcare Corporation (OTC: UAHC), an emerging technology holding company, today announced the appointment of Dr. Katrina Cornish as scientific advisor of its [...]
Bio-Path Holdings to Present Data at the 2019 AACR Annual Meeting
28/02/2019
HOUSTON, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Genocea Reports Fourth Quarter 2018 Results and Announces Hiring of New Chief Financial Officer
28/02/2019
Company advancing lead clinical-stage neoantigen cancer vaccine candidate and expanding pipeline into adoptive cell therapy Diantha Duvall to join as CFO, bringing broad life science financial leadership experience [...]
GeneDx Joins Rare Disease Organizations to Support Rare Disease Day 2019
28/02/2019
Employees Nationwide Participate in Rare Disease Day Virtual Race Campaign GAITHERSBURG, Md., Feb. 28, 2019 (GLOBE NEWSWIRE) -- GeneDx, Inc., a subsidiary of OPKO Health, Inc.’s BioReference Laboratories, Inc. and [...]
Aduro Biotech Announces Upcoming Presentations at AACR Annual Meeting 2019
28/02/2019
BERKELEY, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that three abstracts will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2019, [...]
Retrophin Recognizes Rare Disease Day® 2019 and Honors People Living with Rare Disease and Their Caregivers
28/02/2019
SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today joins the National Organization for Rare Disorders (NORD), the European Organisation for Rare Diseases (EURORDIS), and others worldwide [...]

Pages